Epitopea, an Anglo-Canadian company developing accessible, off-the-shelf RNA-based immunotherapies for cancer, has announced a license and research collaboration deal with US pharma giant Merck & Co ...
This study is the first to demonstrate that certain tRNA introns influence gene expression. Scientists have discovered that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback